September 18, 2015

The Centers for Disease Control and prevention this week announced that a new draft guideline for prescribing opioids to patients with chronic pain was in the works. 

September 11, 2015

Egalet Corporation on Thursday launched (oxycodone HCI) in the U.S.

September 10, 2015

However, patients in the 10-17 years age group also showed the greatest improvement in appropriate prescription drug use compared to all other age groups over a four-year period.

August 19, 2015

A study conducted by researchers at Johns Hopkins Bloomberg School of Public Health has found that Florida’s legislative efforts to curb opioid abuse seem to be having their desired effect. 

August 17, 2015

The website includes sections about the importance of preventing abuse of prescription drugs and outlines the Food and Drug Administrations guidelines on abuse-deterrent labeling. 

July 27, 2015

The Israeli Health Ministry approved on Monday a decision to allow patients licensed to receive medical marijuana from a pharmacy with authorization from a medical expert, according to theJerusalem Post.

June 15, 2015

Carun Pharmacy, the United Kingdom’s first cannabis pharmacy, officially opened its doors in May in Twickenham, London, offering consumers a range of health and beauty products that harness the healing powers of hemp.

June 10, 2015

Despite high-profile efforts to implement abuse-deterrent labels and properties on brand-name opioids, advisory company Avalere Health’s latest research notes a key blind spot in the efforts — accessibility.

May 19, 2015

Pharmacy Quality Alliance has endorsed three new performance measures to assess the use of opioids. 

May 14, 2015

Carun UK, the U.K.’s first cannabis pharmacy, to offer a range of health and beauty products using the “healing powers” of hemp.

April 8, 2015

Hi-Tech Pharmaceuticals on Tuesday contended the findings in a Drug Testing and Analysis study. 

April 7, 2015

Harvard researcher on Tuesday reported that BMPEA, an amphetamine isomer, was found in supplements containing the ingredient Acacia rigidula. 

March 23, 2015

Acura Pharmaceutical's Nexafed extended release demonstrated bioequivalence to Sudafed 12-hour tablets. 

March 11, 2015

Mylan expanded its portfolio of generic products with the U.S. launch of buprenorphine hydrochloride sublingual tablets in 2-mg and 8-mg strengths, the generic version of Subutex from Reckitt Benckiser.

February 27, 2015

Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker. 

February 20, 2015

Actavis on Friday gained approval for a generic version of Reckitt Benckiser's Subutex, indicated for the treatment of opioid dependence.

February 18, 2015

Acura Pharmaceuticals on Monday announced the initiation of treatment in a pilot clinical study of two experimental formulations of Nexafed (pseudoephedrine HCl) extended-release tablets.

February 2, 2015

The Food and Drug Administration announced that it has expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults, making it the first FDA-approved medicine to treat this condition.


January 14, 2015

Egalet Corp. last week announced the licensing and acquisition of two pain products. Egalet has agreed to license worldwide rights to Oxaydo (oxycodone HCI, USP) tablets for oral use only -CII, the first and only approved immediate-release oxycodone product formulated to deter abuse via snorting from Acura Pharmaceuticals, the company stated.

December 16, 2014

Use of cigarettes, alcohol and abuse of prescription pain relievers among teens has declined since 2013, while marijuana use rates were stable, according to the 2014 Monitoring the Future survey, released Tuesday.

December 9, 2014

From 2009 to 2013, the number of Americans using prescription opiates declined 9.2%, yet both the number of opioid prescriptions filled and the number of days of medication per prescription rose more than 8% in that time period. 

December 2, 2014

Teva Pharmaceuticals on Monday announced the introduction and availability of Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, CIII.

October 27, 2014

The National Association of Drug Diversion Investigators on Friday highlighted the latest results achieved by Alabama's real-time, stop-sale pseudoephedrine tracking system.

October 22, 2014

Pfizer last week announced that the Food and Drug Administration approved a revised label for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release capsules, for oral use, CII, to include abuse-deterrence studies.